COMPANY PROFILE // THE 014 REPORT

OKYO Pharma Ltd

OKYO (Nasdaq)

Assembled from 2 government sources in 0.1 s

Built from public records at 2026-11-19 14:34 ET. Every figure links to its source. Flags and checks built 2026-11-19 21:24 ET. Sources

FLAGS · DISCLOSURE · SUMMARY

Missing or hidden

No flag from the records checked. 26 of 26 lists and sources checked came back clear (panel below).

✓ SEC filings✓ State registrationpossible match✗ LEI✗ SAM registration✗ IRS return✗ Website✗ Lobbying registration

No LEI, no SAM registration, no IRS return, no website, no lobbying registration on record.

OKYO Pharma Ltd is an SEC-registered company in biological products, (no diagnostic substances), based in London, United Kingdom; listed as OKYO (Nasdaq).[source] It has filed 86 documents with the SEC in the last 12 months; the latest is Form 6-K, filed 2026-11-12.[source] Its largest institutional holders on 13F filings are Woodline Partners LP, Stonepine Capital Management, LLC, Maven Securities LTD (as of 2026-06-30).[source] Every list and source checked for this page came back clear (26 of 26), dated in the checks panel.[source]

0federal award recipients matched by name in USAspending
0lobbying filings name it as client
86SEC filings in the last 12 months
$9.7Mheld by its 10 largest 13F holders (as of 2026-06-30)
SEC filings by month, 24 months
2024-12: 02025-01: 32025-02: 12025-03: 32025-04: 12025-05: 32025-06: 22025-07: 32025-08: 22025-09: 12025-10: 32025-11: 42025-12: 42026-01: 52026-02: 172026-03: 72026-04: 22026-05: 62026-06: 92026-07: 212026-08: 82026-09: 32026-10: 12026-11: 22024-122026-11
Flags by level
  • red0
  • amber0
  • info0
Largest 13F holders, value as filed
  • Woodline Partners LP$5.5M
  • Stonepine Capital Management, LLC$1.3M
  • Maven Securities LTD$1.2M
  • Balyasny Asset Management L.P.$871K
  • Opaleye Management Inc.$563K
  • UBS Group AG$83K
  • XTX Topco Ltd$57K
  • CHOREO, LLC$50K

RECORD · WEB

Ask about this entity

Answers come from this 014 first; every line is marked RECORD (our record, linked) or WEB (a web page, credited and linked).

PEOPLE · COUNSEL · LINKS

Leadership, advisers and links

Officers and directors (Forms 3, 4, 5)

  • JACOB GARY S · Chief Development Officer (Director,Officer) · latest Form 3 2026-03-18 · filing · LinkedIn search
  • CERRONE GABRIELE M · Director,10% owner · latest Form 3 2026-03-18 · filing · LinkedIn search

As reported to the SEC by the insiders themselves; SEC insider transactions data sets (Forms 3, 4, 5): 2026q1, 2025q4, 2025q3, 2025q2.

EVERY LIST AND SOURCE · DATED

Checked and clear

26 lists and sources checked: 26 CLEAR, 0 POSSIBLE MATCH, 0 MATCH. Screening lists are checked when this 014 is built; the enforcement and registry sources at the last company-engine build. Each date is the date of that check.

List or sourceResultCheckedWhat matched
OFAC SDN (Treasury)CLEAR2026-11-18
SAM.gov exclusionsCLEAR2026-11-19
HHS-OIG LEIECLEAR2026-11-13
FARA registrants (DOJ)CLEAR2026-11-19
Regulated facility: compliance, penalties and TRI parent (EPA)CLEAR2026-11-18
Hazardous-waste handler facility (EPA RCRAInfo, sample)CLEAR2026-11-18
Consumer complaints about a company (CFPB)CLEAR2026-11-18
Corporate enforcement action (DOJ, SEC, CFTC, EPA)CLEAR2026-11-18
SEC litigation release (respondent)CLEAR2026-11-18
Federal Reserve Board enforcement action (press release, 2022 onward)CLEAR2026-11-18
Enforcement order against a savings association (OCC, OTS archive to 2011)CLEAR2026-11-18
State environmental enforcement actions (Maryland MDE, Connecticut DEEP)CLEAR2026-11-18
Firm sanctioned or debarred by the IDB Group (incl. cross-debarments by WBG, ADB, EBRD, AfDB as listed by the IDB)CLEAR2026-11-18
UK sanctions designation (FCDO UK Sanctions List)CLEAR2026-11-18
US export screening list party (Consolidated Screening List, ITA)CLEAR2026-11-18
FDA recallCLEAR2026-11-18
FDA import alert or listed firm (Red / Yellow / Green list)CLEAR2026-11-18
Consumer product recall or recalling firm (CPSC, full history)CLEAR2026-11-18
Consumer product recall (CPSC)CLEAR2026-11-18
Vehicle recall, defect investigation or manufacturer (NHTSA ODI)CLEAR2026-11-18
Vehicle recall (NHTSA)CLEAR2026-11-18
FinCEN enforcement action (civil money penalty or consent order, 1999 onward)CLEAR2026-11-18
Union representation election (NLRB)CLEAR2026-11-18
NYC summons against an organization, adjudicated at OATH (all city agencies)CLEAR2026-11-18
Data breach notice to a state Attorney GeneralCLEAR2026-11-18
Data breach notice (California Attorney General)CLEAR2026-11-18

EVERY IDENTIFIER · LINKED

ID crosswalk

IdentifierValueRecord
SEC CIK0001849296source
EIN00-0000000source
NY DOS IDpossible match6001489record
Business address (SEC)55 PARK LANE, LONDON, X0, W1K 1NAsource

Does not exist in the records we hold: LEI, UEI, FDIC certificate.

EACH FEEDS WATCH

Dates coming up

No dated renewal or filing deadline is held for this entity: no SAM registration, no LEI and no periodic filing schedule on record.

PEERS BY SIC CODE

Industry context

SIC 2836 (biological products, (no diagnostic substances)): 183 companies in our records share this code.

#11 of 183
federal dollars
#13 of 183
lobbying filings
#45 of 183
SEC filings in 12 months
#112 of 183
flags

Peers, each with its 014

EVERY SOURCE · NEWEST FIRST

One timeline

170 earlier entries
  • 2026-02-23 filing 6-K
  • 2026-02-17 filing 424B5
  • 2026-02-13 filing 6-K
  • 2026-02-13 filing 6-K
  • 2026-02-12 filing 6-K
  • 2026-02-12 filing 424B5
  • 2026-02-11 filing 6-K
  • 2026-02-11 filing 6-K
  • 2026-02-11 filing 424B5
  • 2026-02-10 filing EFFECT
  • 2026-02-10 filing 6-K
  • 2026-02-06 filing UPLOAD
  • 2026-02-06 filing CORRESP
  • 2026-02-02 filing F-3
  • 2026-01-30 filing 6-K
  • 2026-01-30 filing 6-K
  • 2026-01-28 filing 6-K
  • 2026-01-23 filing 6-K
  • 2026-01-05 filing 6-K
  • 2025-12-19 filing 6-K
  • 2025-12-15 filing 6-K
  • 2025-12-11 filing 6-K
  • 2025-12-03 filing 6-K
  • 2025-11-21 filing 6-K
  • 2025-11-18 filing 6-K
  • 2025-10-29 filing 6-K
  • 2025-10-16 filing 6-K
  • 2025-09-22 filing 6-K
  • 2025-08-12 filing 20-F/A
  • 2025-07-18 filing Annual report (20-F)
  • 2025-07-17 filing 6-K
  • 2025-07-16 filing 6-K
  • 2025-06-11 filing 6-K
  • 2025-06-11 filing 424B5
  • 2025-05-19 filing 6-K
  • 2025-05-01 filing 6-K
  • 2025-04-30 filing 6-K
  • 2025-03-31 filing 6-K
  • 2025-03-10 filing 6-K
  • 2025-02-12 filing 6-K
  • 2025-01-31 filing 6-K
  • 2025-01-29 filing 6-K
  • 2025-01-22 filing 6-K
  • 2024-11-26 filing 6-K
  • 2024-10-30 filing 6-K
  • 2024-10-23 filing 6-K
  • 2024-10-16 filing 6-K
  • 2024-09-10 filing 6-K
  • 2024-09-05 filing 6-K
  • 2024-08-27 filing 6-K
  • 2024-08-23 filing 6-K
  • 2024-08-23 filing 6-K
  • 2024-08-21 filing 6-K
  • 2024-08-15 filing 6-K
  • 2024-08-13 filing Annual report (20-F)
  • 2024-08-06 filing 6-K
  • 2024-07-31 filing NT 20-F
  • 2024-07-11 filing 6-K
  • 2024-07-10 filing 6-K
  • 2024-07-10 filing 6-K
  • 2024-05-08 filing 6-K
  • 2024-04-30 filing 6-K
  • 2024-04-09 filing 6-K
  • 2024-04-04 filing 6-K
  • 2024-04-02 filing 6-K
  • 2024-03-29 filing 6-K
  • 2024-03-22 filing 6-K
  • 2024-03-21 filing 6-K
  • 2024-03-20 filing 6-K
  • 2024-02-09 filing 6-K
  • 2024-01-31 filing 6-K
  • 2024-01-08 filing 6-K
  • 2024-01-05 filing 6-K
  • 2023-12-21 filing 6-K
  • 2023-12-20 filing 424B5
  • 2023-12-18 filing 6-K
  • 2023-12-18 filing 424B5
  • 2023-12-04 filing 6-K
  • 2023-11-29 filing 6-K
  • 2023-11-01 filing 6-K
  • 2023-10-31 filing 424B5
  • 2023-10-31 filing 6-K
  • 2023-10-10 filing 6-K
  • 2023-10-05 filing 6-K
  • 2023-09-15 filing 6-K
  • 2023-09-15 filing 6-K
  • 2023-09-15 filing 424B5
  • 2023-09-14 filing 6-K
  • 2023-09-14 filing 6-K
  • 2023-09-13 filing 424B5
  • 2023-09-13 filing 6-K
  • 2023-09-08 filing 6-K
  • 2023-08-30 filing 6-K
  • 2023-08-29 filing 6-K
  • 2023-08-25 filing 20-F/A
  • 2023-08-15 filing 6-K
  • 2023-08-15 filing Annual report (20-F)
  • 2023-07-31 filing NT 20-F
  • 2023-07-31 filing 6-K
  • 2023-07-28 filing FWP
  • 2023-07-28 filing 6-K
  • 2023-07-28 filing 424B5
  • 2023-07-28 filing 6-K
  • 2023-07-28 filing 6-K
  • 2023-07-27 filing 6-K
  • 2023-06-15 filing 424B3
  • 2023-06-14 filing EFFECT
  • 2023-06-14 filing EFFECT
  • 2023-06-12 filing CORRESP
  • 2023-06-12 filing CORRESP
  • 2023-06-12 filing UPLOAD
  • 2023-06-09 filing F-1/A
  • 2023-06-08 filing F-1/A
  • 2023-06-08 filing F-3
  • 2023-06-06 filing 6-K
  • 2023-06-02 filing CORRESP
  • 2023-06-02 filing F-1/A
  • 2023-06-02 filing 8-A12B/A
  • 2023-05-30 filing UPLOAD
  • 2023-05-22 filing 6-K
  • 2023-05-19 filing 6-K
  • 2023-05-17 filing F-1
  • 2023-05-15 filing 6-K
  • 2023-05-11 filing 6-K
  • 2023-05-11 filing 6-K
  • 2023-05-03 filing 6-K
  • 2023-05-03 filing 6-K
  • 2023-05-03 filing 6-K
  • 2023-05-02 filing 6-K
  • 2023-04-25 filing 6-K
  • 2023-04-05 filing 6-K
  • 2023-04-04 filing 6-K
  • 2023-03-30 filing 6-K
  • 2023-03-29 filing 6-K
  • 2023-03-24 filing 6-K
  • 2023-03-16 filing 6-K
  • 2023-03-15 filing 6-K
  • 2023-03-15 filing 6-K
  • 2023-03-14 filing 424B4
  • 2023-03-14 filing 6-K
  • 2023-03-13 filing 6-K
  • 2023-03-08 filing EFFECT
  • 2023-03-03 filing POS AM
  • 2023-02-28 filing 6-K
  • 2023-02-27 filing EFFECT
  • 2023-02-23 filing CORRESP
  • 2023-02-23 filing CORRESP
  • 2023-02-23 filing 6-K
  • 2023-02-22 filing F-1/A
  • 2023-02-21 filing 6-K
  • 2023-02-17 filing F-1/A
  • 2023-02-14 filing 6-K
  • 2023-01-19 filing FWP
  • 2023-01-19 filing F-1/A
  • 2023-01-17 filing CORRESP
  • 2023-01-17 filing CORRESP
  • 2023-01-17 filing CORRESP
  • 2023-01-13 filing RW WD
  • 2023-01-12 filing CORRESP
  • 2023-01-12 filing RW
  • 2023-01-10 filing CORRESP
  • 2023-01-10 filing CORRESP
  • 2023-01-05 filing CORRESP
  • 2023-01-04 filing 6-K
  • 2023-01-03 filing CORRESP
  • 2023-01-03 filing CORRESP
  • 2023-01-03 filing FWP
  • 2023-01-03 filing F-1/A
  • 2023-01-03 filing 6-K
  • 2022-12-30 filing 6-K

RENDERED FROM THIS PAGE

Relationship graph

Holders from 13F filings, subsidiaries from the GLEIF tree (by LEI), lobbying firms from LDA (possible match), agencies from USAspending, people from Forms 3/4/5, counsel from Exhibit 5.1, shared boards from Forms 3/4/5.

DATA MOTION // NEWEST FIRST

What changed

Dot rule: red = within 7 days, amber = within 30 days, green = older. Measured against 2026-11-19; the colour is also written out in words.

COUNTS FROM THIS PAGE

Relationships at a glance

10largest institutional holders (13F as filed)
0other entities in the GLEIF ownership tree (ID tier)
0awarding federal agencies
0hiring lobbying firms: possible match: matched by name only, not merged
PRICE · FILINGS · POSTS · NEWS

Market & news

Price
NASDAQ:OKYO The chart widget (TradingView) shows the price and the previous session's close. Seraphix publishes no price of its own.
Open in
Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

Financials
Filed figures: published SEC values, each linked to its filing.
Official posts
Links to posts from the company's and agencies' verified accounts: not connected yet.
News
Article links (headline, date, link): not connected yet.
EVERY RESOLVED IDENTIFIER

1. Identity

1confirmed members (SEC registrant + GLEIF ownership tree)
0legal entities (LEI) in the ownership tree
25dated filings and events

2 possible matches held apart, matched by name only, not counted above.

IdentifierValueHow it was resolvedSource
SEC CIK1849296id:sec-anchor: the SEC registrant record of this companySEC EDGAR
Ticker / exchangeOKYO / NasdaqSEC company record: ticker and exchange as listed on the SEC company recordSEC EDGAR
CUSIPG6724L116carried on the SEC-anchored record: listed in the identifiers of sx:sec:0001849296SEC EDGAR
AS FILED · EACH WITH ITS DATE AND FILING

2. Filed figures

Key figures (annual filing)

FigureValuePeriod or as ofSourceBasisRetrievedReport
Net income (loss) (fiscal year ended 2025-03-31)-$4,706,2922025-03-3120-F, XBRL ProfitLossas filed2026-11-19 19:34 UTCReport an error
Total assets (at 2025-03-31)$3,677,3362025-03-3120-F, XBRL Assetsas filed2026-11-19 19:34 UTCReport an error

Company profile facts (SEC)

FigureValuePeriod or as ofSourceBasisRetrievedReport
SEC entity typeother2026-11-12SEC EDGAR company profileas filed2026-11-19 19:34 UTCReport an error
SIC industry2836 Biological Products, (No Diagnostic Substances)2026-11-12SEC EDGAR company profileas filed2026-11-19 19:34 UTCReport an error
Business address55 PARK LANE, LONDON, X0, W1K 1NA2026-11-12SEC EDGAR company profileas filed2026-11-19 19:34 UTCReport an error
ExchangesNasdaq2026-11-12SEC EDGAR company profileas filed2026-11-19 19:34 UTCReport an error

No estimates: every value is as filed and links to the filing it came from.

Registration: the SEC filer status is under "Company profile facts (SEC)" above. SAM.gov registration status: not held yet.

NEWEST FIRST · EACH LINKS TO ITS FILING

3. Registration and filing timeline

AS FILED · LARGEST HOLDERS

10. 13F institutional holders

RankHolder (13F filer)Value heldAs ofSourceRetrievedReport
1Woodline Partners LP$5,479,1522026-06-30SEC 13F filing2026-11-19 19:34 UTCReport an error
2Stonepine Capital Management, LLC$1,294,4942026-06-30SEC 13F filing2026-11-19 19:34 UTCReport an error
3Maven Securities LTD$1,213,9762026-06-30SEC 13F filing2026-11-19 19:34 UTCReport an error
4Balyasny Asset Management L.P.$870,8942026-06-30SEC 13F filing2026-11-19 19:34 UTCReport an error
5Opaleye Management Inc.$562,8062026-06-30SEC 13F filing2026-11-19 19:34 UTCReport an error
6UBS Group AG$82,5142026-06-30SEC 13F filing2026-11-19 19:34 UTCReport an error
7XTX Topco Ltd$56,6542026-06-30SEC 13F filing2026-11-19 19:34 UTCReport an error
8CHOREO, LLC$49,8832026-06-30SEC 13F filing2026-11-19 19:34 UTCReport an error
9Quantinno Capital Management LP$49,8822026-06-30SEC 13F filing2026-11-19 19:34 UTCReport an error
10Cerity Partners LLC$19,2182026-06-30SEC 13F filing2026-11-19 19:34 UTCReport an error

13F as filed: the holder's own report of its position value at the quarter end.

POSSIBLE MATCHES · LICENCES, PERMITS, CITY AND STATE RECORDS

13. Permits and local records

2 state and city records carry this company's exact name, from 2 sources. Possible matches only.

ClinicalTrials.gov (1)

possible match: matched by name only, not merged (1)

Possible match based on name, not a shared identifier. Compare the records.

New York corporations (1)

possible match: matched by name only, not merged (1)

Possible match based on name, not a shared identifier. Compare the records.

WHAT THIS PAGE READ

Sources

As of 2026-11-19 (record built 2026-11-19T19:34:33Z). Sources used: SEC EDGAR, SEC 13F holdings.

Not checked: FTC enforcement actions; DOJ press releases (beyond FARA and the corporate enforcement set); federal and state court records; UCC filings, liens and bankruptcy dockets; IRS automatic revocation list; state annual-report dates; company formation dates (only where a state registry record states one).

JSON · MCP · API

API and agents

The same profile as JSON: GET /company/1849296.json. The MCP server and the records API return the same data: GET /v1/record/sx:sec:0001849296. Every source URL used is listed in the file.

Get the evidence file, alerts and the API with a free key. Everything on this page stays free to read.